Synlett 2009(2): 209-212  
DOI: 10.1055/s-0028-1087669
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Stereoselective Total Synthesis of (+)-Valienamine and (+)-4-epi-Valienamine via a Ring-Closing Enyne Metathesis Protocol

Palakodety Radha Krishna*, P. Srinivas Reddy
D-206/B, Discovery Laboratory, Organic Chemistry Division III, Indian Institute of Chemical Technology, Hyderabad 500607, India
Fax: +91(40)27160387; e-Mail: prkgenius@iict.res.in;
Further Information

Publication History

Received 15 September 2008
Publication Date:
15 January 2009 (online)

Abstract

Stereoselective total synthesis of (+)-valienamine is reported utilizing Sharpless asymmetric dihydroxylation, diastereoselective Carreira alkynylation, and ring-closing enyne metathesis (RCEYM) as key steps from l-serine. A similar strategy is also reported for the first total synthesis of (+)-4-epi-valienamine.

    References and Notes

  • 1 Fleet GWJ. Chem. Br.  1989,  25:  287 
  • 2 Kameda Y. Horii S. J. Chem. Soc., Chem. Commun.  1972,  746 
  • 3a Kameda Y. Asano N. Yoshikawa M. Matsui K. J. Antibiot.  1980,  33:  1573 
  • 3b Kameda Y. Asano N. Teranishi M. Matsui K. J. Antibiot.  1981,  34:  1237 
  • 4a Asano N. Takeuchi M. Ninomiya K. Kameda Y. Matsui K. J. Antibiot.  1984,  37:  859 
  • 4b Ogawa S. Miyamoto Y. J. Chem. Soc., Perkin Trans. 1  1991,  3287 
  • 5a Chen X. Fan Y. Zheng Y. Shen Y. Chem. Rev.  2003,  103:  1963 
  • 5b Mahmud T. Nat. Prod. Rep.  2003,  20:  137 
  • 5c Arjona O. Gómez AN. López JC. Plumet J. Chem. Rev.  2007,  107:  1919 
  • 5d Delgado A. Eur. J. Org. Chem.  2008,  3893 
  • 6a Kameda Y. Asano N. Yoshikawa M. Takeuchi M. Yamaguchi T. Matsui K. J. Antibiot.  1984,  37:  1301 
  • 6b Kameda Y. Asano N. Yoshikawa M. Matsui K. J. Antibiot.  1980,  33:  1575 
  • 7a Takeuchi M. Kamata K. Yoshida M. Kameda Y. Matsui K. J. Biochem.  1990,  108:  42 
  • 7b Takeuchi K. Takai N. Asano N. Kameda Y. Matsui K. Chem. Pharm. Bull.  1990,  38:  1970 
  • 8a Paulsen H. Heiker FR. Angew. Chem., Int. Ed. Engl.  1980,  19:  904 
  • 8b Paulsen H. Heiker FR. Liebigs Ann. Chem.  1981,  2180 
  • 9a Shing TKM. Li TY. Kok SHL. J. Org. Chem.  1999,  64:  1941 
  • 9b Kok SH.-L. Lee CC. Shing TKM. J. Org. Chem.  2001,  66:  7184 
  • 10a Schmidt DD. Köhn A. Angew Chem., Int. Ed. Engl.  1987,  26:  482 
  • 10b Nicotra F. Panza L. Ronchetti F. Russo G. Gazz. Chim. Ital.  1989,  119:  577 
  • 10c Park TK. Danishefsky SJ. Tetrahedron Lett.  1994,  35:  2667 
  • 11a Kapferer P. Sarabia F. Vasella A. Helv. Chim. Acta  1999,  82:  645 
  • 11b Chang YK. Young BL. Kim DJ. Lee GS. Jeon HB. Kim KS. J. Org. Chem.  2005,  70:  3299 
  • 11c Cumpstey I. Tetrahedron Lett.  2005,  46:  6257 
  • 12a Radha Krishna P. Narsingam M. Kannan V. Tetrahedron Lett.  2004,  45:  4773 
  • 12b Radha Krishna P. Dayakar G. Tetrahedron Lett.  2007,  48:  7279 
  • 12c Radha Krishna P. Srinivas Reddy P. Tetrahedron  2007,  63:  3995 
  • 12d Radha Krishna P. Narsingam M. Tetrahedron Lett.  2007,  48:  8721 
  • 13 Ogawa S. Kanto M. J. Nat. Prod.  2007,  70:  493 
  • 14 Blackburn L. Wei X. Taylor RJK. Chem. Commun.  1999,  1337 
  • 15 Frantz DE. Fässler R. Carreira EM. J. Am. Chem. Soc.  2000,  122:  1806 
  • 16a Guillarme S. Ple K. Banchet A. Liard A. Haudrechy A. Chem. Rev.  2006,  106:  2355 
  • 16b Guillarme S. Haudrechy A. Tetrahedron Lett.  2005,  46:  3175 
  • 17a Diver ST. Giessert AJ. Chem. Rev.  2004,  104:  1317 
  • 17b Mori M. Sakakibara N. Kinoshita A. J. Org. Chem.  1998,  63:  6082 
  • 19 Matsuda J. Suzuki O. Oshima A. Yamamoto Y. Noguchi A. Takimoto K. Itoh M. Matsuzaki Y. Yasuda Y. Ogawa S. Sakata Y. Nanba E. Hizaki K. Ogawa Y. Tominaga L. Ohno K. Iwasaki H. Watanabe H. Brady RO. Suzuki Y. Proc. Natl. Acad. Sci. U.S.A.  2003,  100:  15912 
18

Spectral data for selected compounds: Compound 10b: light yellow syrup; [α]D ²5 +11.96 (c = 0.59, CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 6.01 (m, 2 H), 5.20-5.34 (m, 2 H), 4.89 (q, 1 H, J = 8.8, 15.4 Hz), 4.80 (dd, 1 H, J = 4.0, 7.0 Hz), 4.66-4.76 (m, 2 H), 4.50-4.62 (m, 2 H), 4.38 (br s, 1 H), 4.02 (t, 1 H, J = 3.3 Hz), 3.76-3.83 (m, 2 H), 3.46 (s, 3 H), 3.43 (s, 3 H), 3.36 (s, 3 H), 2.46 (d, 1 H, J = 1.8 Hz), 1.44 (s, 9 H). ¹³C NMR (75 MHz, CDCl3): δ = 155.6, 135.1, 116.6, 99.3, 97.2, 94.4, 79.5, 79.4, 77.9, 76.0, 67.1, 56.8, 56.1, 55.9, 53.8, 28.3. IR (neat): 3425, 3252, 2930, 2250, 2154, 1714, 1640, 1502, 1158, 1026 cm. HRMS: m/z [M + Na]+ calcd for C19H33NO8Na: 426.2103; found: 426.2107. Compound 11b: light yellow syrup; [α]D ²5 -77.21 (c = 0.76, CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 6.24 (dd, 1 H, J = 11.0, 17.4 Hz), 5.78 (dd, 1 H, J = 3.0, 15.9 Hz), 5.44 (d, 1 H, J = 16.9 Hz), 5.10 (d, 1 H, J = 10.9 Hz), 4.90 (dd, 1 H, J = 3.4, 7.1 Hz), 4.60-4.82 (m, 6 H), 4.50 (br d, 1 H, J = 2.2 Hz), 4.29 (br s, 1 H), 4.10 (dd, 1 H, J = 2.2, 5.2 Hz), 3.86 (t, 1 H, J = 4.9 Hz), 3.42 (s, 3 H), 3.40 (s, 3 H), 3.39 (s, 3 H), 1.45 (s, 9 H). ¹³C NMR (75 MHz, CDCl3): δ = 155.6, 136.6, 135.2, 129.5, 114.4, 96.4, 96.3, 95.9, 79.4, 73.5, 72.7, 72.4, 56.3, 55.8, 55.6, 29.0. IR (neat): 3416, 2925, 2854, 1717, 1609, 1510, 1156, 1024 cm. HRMS: m/z [M + H]+ calcd for C19H34NO8: 404.2284; found: 404.2279. Compound 13b: white solid; mp 94 ˚C; [α]D ²5 +22.7 (c = 0.62, CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 5.87 (d, 1 H, J = 4.4 Hz), 5.79 (br d, 1 H, J = 8.4 Hz), 5.43 (dd, 1 H, J = 6.4, 9.4 Hz), 5.34 (d, 1 H, J = 6.3 Hz), 4.98-5.10 (m, 2 H), 4.63 (d, 1 H, J = 13.2 Hz), 4.36 (d, 1 H, J = 13.2 Hz), 2.01-2.06 (m, 15 H). ¹³C NMR (75 MHz, CDCl3): δ = 170.3, 170.2, 170.1, 169.9, 169.8, 134.3, 126.1, 71.2, 69.0, 68.5, 62.9, 44.8, 23.3, 20.7. IR (neat): 3287, 2925, 1746, 1658, 1371, 1225, 1031 cm. HRMS: m/z [M + Na]+ calcd for C17H23NO9Na: 408.1270; found: 408.1263. Compound 10a: syrupy liquid; [α]D ²5
-187.0 (c = 0.55, CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 5.79-5.97 (m, 1 H), 5.15-5.32 (m, 2 H), 4.91 (q, 1 H, J = 8.3, 15.1 Hz), 4.75 (dd, 3 H, J = 6.0, 17.3 Hz), 4.60 (t, 2 H, J = 6.8, 15.1 Hz), 4.37-4.46 (m, 1 H), 3.91 (t, 1 H, J = 5.2 Hz), 3.78 (m, 2 H), 3.44 (s, 3 H), 3.37 (m, 6 H), 2.44 (d, 1 H, J = 2.2 Hz), 1.44 (s, 9 H). ¹³C NMR (75 MHz, CDCl3): δ = 155.3, 134.9, 112.3, 98.6, 96.9, 92.7, 79.8, 79.1, 78.4, 77.2, 66.8, 57.4, 56.7, 56.0, 52.9, 28.2. IR (neat): 3438, 3210, 2927, 2852, 2140, 1715, 1610, 1506, 1156, 1026 cm. HRMS: m/z calcd for C19H34NO8: 404.2284; found: 404.2291. Compound 11a: light yellow syrup; [α]D ²5 +62.68 (c = 2.6, CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 6.27 (dd, 1 H, J = 11.0, 17.5 Hz), 5.80 (br d, 1 H, J = 2.8 Hz), 5.44 (d, 1 H, J = 17.5 Hz), 5.06-5.12 (m, 2 H), 4.80 (d, 1 H, J = 7.0 Hz), 4.60-4.74 (m, 6 H), 4.28 (br s, 1 H), 4.10 (dd, 1 H, J = 2.1, 5.2 Hz), 3.86 (t, 1 H, J = 5.2 Hz), 3.42 (s, 3 H), 3.41 (s, 3 H), 3.39 (s, 3 H), 1.45 (s, 9 H). ¹³C NMR (75 MHz, CDCl3): δ = 155.4, 136.8, 133.4, 129.0, 112.6, 97.5, 96.9, 96.3, 80.1, 74.7, 71.9, 71.0, 57.2, 56.0, 55.7, 28.3. IR (neat): 3366, 2925, 1714, 1158, 1020 cm. HRMS: m/z [M + H]+ calcd for C19H34NO8: 404.2284; found: 404.2280. Compound 13a: thick white syrup; [α]D ²5 +69.6 (c = 0.58, CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 5.99 (d, 1 H, J = 5.3 Hz), 5.82 (d, 1 H, J = 8.3 Hz), 5.44 (dd, 1 H, J = 6.8, 11.5 Hz), 5.27 (br dd, 1 H, J = 4.1, 6.2 Hz), 4.96-5.07 (m, 2 H), 4.66 (dd, 1 H, J = 1.5, 12.8 Hz), 4.33 (dd, 1 H, J = 1.5, 13.6 Hz), 2.07 (s, 3 H), 2.06 (s, 3 H), 2.05 (s, 3 H), 2.02 (s, 3 H), 2.00 (s, 3 H). ¹³C NMR (75 MHz, CDCl3): δ = 170.5, 170.2, 170.1, 169.9, 169.8, 132.2, 127.0, 72.7, 70.9, 66.0, 62.2, 46.7, 23.1, 20.6. IR (neat): 3447, 2963, 1742, 1647, 1260, 1020 cm. HRMS: m/z [M + Na]+ calcd for C17H23NO9Na: 408.1270; found: 408.1265.